{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T04:52:33Z","timestamp":1772081553234,"version":"3.50.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.semnephrol.2014.09.004","type":"journal-article","created":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T21:46:24Z","timestamp":1418852784000},"page":"612-625","source":"Crossref","is-referenced-by-count":56,"title":["When, How, and Why a Bone Biopsy Should Be Performed in Patients With Chronic Kidney Disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Pablo Ure\u00f1a","family":"Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Bover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Mazzaferro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Christine","family":"de Vernejoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Cohen-Solal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2014.09.004_bib1","series-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","first-page":"3","article-title":"Anatomy and ultrastructure of bone","author":"Baron","year":"1993"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-8587(14)70059-2","article-title":"Bone: a new endocrine organ at the heart of chronic kidney disease and mineral disorders","volume":"2","author":"Vervloet","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib3","series-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","first-page":"21","article-title":"Bone matrix proteins and the mineralization process","author":"Termine","year":"1993"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1053\/j.ajkd.2006.11.045","article-title":"Minimodeling reduces the rate of cortical bone loss in patients with secondary hyperparathyroidism","volume":"49","author":"Yajima","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib5","first-page":"101","article-title":"Osteocyte biology: its implications for osteoporosis","volume":"4","author":"Bonewald","year":"2004","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib6","series-title":"The kidney","first-page":"2103","article-title":"Renal osteodystrophies","author":"Llach","year":"2000"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib7","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.1994.342","article-title":"Evidence for abnormal calcium homeostasis in patients with adynamic bone disease","volume":"46","author":"Kurz","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJM198908033210509","article-title":"Renal osteodystrophy","volume":"321","author":"Malluche","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000415727","article-title":"Bone biopsy studies in the diagnosis and treatment of renal osteodystrophy","volume":"64","author":"Sebert","year":"1988","journal-title":"Contrib Nephrol"},{"issue":"10","key":"10.1016\/j.semnephrol.2014.09.004_bib10","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/ndt\/gft514","article-title":"Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?","volume":"29","author":"Cozzolino","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib11","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib12","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.ki.5001606","article-title":"Inter-method variability in PTH measurement: implication for the care of CKD patients","volume":"70","author":"Souberbielle","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/sj.ki.5001658","article-title":"The need for a reliable serum parathyroid hormone measurements","volume":"70","author":"Urena","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5002769","article-title":"K\/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients","volume":"73","author":"Barreto","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib16","first-page":"905","article-title":"Bone alkaline phosphatase (BAP) compared to PTH in the diagnosis of adynamic bone disease (ABD) [abstract]","volume":"9","author":"Couttenye","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib17","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","author":"Urena","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0221-8747(81)90005-9","article-title":"Bone histomorphometry in hemodialysed patients","volume":"3","author":"deVernejoul","year":"1981","journal-title":"Metab Bone Dis Relat Res"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib19","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.V491631","article-title":"The role of bone biopsy in the management of patients with renal osteodystrophy","volume":"4","author":"Malluche","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF02058664","article-title":"Tetracycline-based histological analysis of bone remodeling","volume":"3","author":"Frost","year":"1969","journal-title":"Calcif Tissue Res"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1525-139X.2003.160631.x","article-title":"Bone biopsy: indications, techniques, and complications","volume":"16","author":"Trueba","year":"2003","journal-title":"Semin Dial"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib23","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1007\/s11999-010-1692-y","article-title":"Raman assessment of bone quality","volume":"469","author":"Morris","year":"2011","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MNH.0b013e32835dda01","article-title":"Bone biopsy in renal osteodystrophy: continued insights into a complex disease","volume":"22","author":"Christov","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1210\/jcem-39-1-119","article-title":"Quantitative histological studies on the pathogenesis of uremic bone disease","volume":"39","author":"Sherrard","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib27","first-page":"112","article-title":"Transiliac bone biopsy. Complications and diagnostic value","volume":"28","author":"Rao","year":"1980","journal-title":"Henry Ford Hosp Med J"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00198-013-2435-1","article-title":"Incidence and risk factors for hip fractures in dialysis patients","volume":"25","author":"Maravic","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib29","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1046\/j.1523-1755.63.s85.13.x","article-title":"The renal osteodystrophy pattern in Brazil and Uruguay: an overview","volume":"85","author":"Araujo","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib30","first-page":"57","article-title":"Fractures and vertebral bone mineral density in patients with renal osteodystrophy","volume":"30","author":"Piraino","year":"1988","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib31","first-page":"437","article-title":"Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis","volume":"13","author":"Gerakis","year":"2000","journal-title":"J Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM198502213120803","article-title":"Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure","volume":"312","author":"Andress","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib33","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/ki.1987.75","article-title":"The interaction of parathyroid hormone and aluminum in renal osteodystrophy","volume":"31","author":"Slatopolsky","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib34","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib35","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.ajkd.2012.06.019","article-title":"Severe hypocalcemia following denosumab injection in a hemodialysis patient","volume":"60","author":"McCormick","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib36","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1210\/jc.2014-1154","article-title":"An open-label, prospective pilot clinical study of denosumab for severe hyperparathyroidism in patients with low bone mass undergoing dialysis","volume":"99","author":"Chen","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib37","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1096\/fj.05-4221fje","article-title":"Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation","volume":"19","author":"Poole","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib38","doi-asserted-by":"crossref","first-page":"e2942","DOI":"10.1371\/journal.pone.0002942","article-title":"Control of bone mass and remodeling by PTH receptor signaling in osteocytes","volume":"3","author":"O\u05f3Brien","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib39","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with osteopenia","volume":"370","author":"McClung","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib40","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib41","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/beta-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib42","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/oxfordjournals.ndt.a027089","article-title":"PTH\/PTHrP receptor mRNA is down-regulated in epiphyseal cartilage growth plate of uraemic rats","volume":"11","author":"Urena","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jbmr.173","article-title":"Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody","volume":"26","author":"Padhi","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib44","first-page":"1046","article-title":"Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease","volume":"77","author":"Garnero","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib45","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1073\/pnas.83.19.7182","article-title":"Isolation and characterization of a cDNA encoding a human liver\/bone\/kidney-type alkaline phosphatase","volume":"84","author":"Weiss","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib46","doi-asserted-by":"crossref","first-page":"12002","DOI":"10.1016\/S0021-9258(18)37885-2","article-title":"Structure of the human liver\/bone\/kidney-type alkaline phosphatase gene","volume":"263","author":"Weiss","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib47","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/281152a0","article-title":"Evidence that three structural genes code for human alkaline phosphatases","volume":"281","author":"Seargeant","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib48","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.1073\/pnas.85.20.7666","article-title":"A missense mutation in the human liver\/bone\/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia","volume":"85","author":"Weiss","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib49","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1210\/jcem-69-6-1166","article-title":"Relationships between histomorphometric features of bone formation and bone cell characteristics in vitro in renal osteodystrophy","volume":"69","author":"Marie","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib50","first-page":"2587","article-title":"Aberrant properties of alkaline phosphatase in patient fibroblasts correlate with clinical expressivity in severe forms of hypophosphatasia","volume":"81","author":"Fedde","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib51","first-page":"3923","article-title":"Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values","volume":"81","author":"Brossard","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib52","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/08860228309076050","article-title":"Hypophosphatemia-induced hypercalcemia during acute renal failure","volume":"7","author":"Gagnon","year":"1983","journal-title":"Clin Exp Dial Apheresis"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib53","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1038\/ki.2011.27","article-title":"Phosphate and FGF-23","volume":"121","author":"Juppner","year":"2011","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib54","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1359\/jbmr.1999.14.5.661","article-title":"Strontium and bone","volume":"14","author":"Cabrera","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib55","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/clinchem\/45.9.1548","article-title":"Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients","volume":"45","author":"D\u05f3Haese","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000186863","article-title":"Deferoxamine test and PTH serum levels are useful not to recognize but to exclude aluminum-related bone disease","volume":"61","author":"Mazzaferro","year":"1992","journal-title":"Nephron"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2014.09.004_bib57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/ndt\/17.suppl_2.21","article-title":"Aluminium and bone disease in chronic renal failure","volume":"17","author":"Malluche","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib58","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/ndt\/17.7.1170","article-title":"Management of hyperphosphataemia of chronic kidney disease: lessons from the past and future directions","volume":"17","author":"Malluche","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2014.09.004_bib59","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ndt\/17.suppl_2.30","article-title":"Strontium overload and toxicity: impact on renal osteodystrophy","volume":"17","author":"Cohen-Solal","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib60","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/ndt\/17.3.449","article-title":"Fluoride and strontium accumulation in bone does not correlate with osteoid tissue in dialysis patients","volume":"17","author":"Cohen-Solal","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib61","first-page":"181","article-title":"[Risk of bone disease as a result of fluoride intake in chronic renal insufficiency]","volume":"6","author":"Noel","year":"1985","journal-title":"Nephrologie"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib62","doi-asserted-by":"crossref","first-page":"339","DOI":"10.7326\/0003-4819-121-5-199409010-00005","article-title":"An outbreak of fatal fluoride intoxication in a long-term hemodialysis unit","volume":"121","author":"Arnow","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib63","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S8756-3282(96)00306-7","article-title":"Reductions in bone strength after fluoride treatment are not reflected in tissue-level acoustic measurements","volume":"19","author":"Turner","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib64","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/8756-3282(89)90004-5","article-title":"Skeletal fluorosis: histomorphometric analysis of bone changes and bone fluoride content in 29 patients","volume":"10","author":"Boivin","year":"1989","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib65","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0009-8981(86)90074-4","article-title":"Increase in blood plasma levels of boron and strontium in hemodialyzed patients","volume":"156","author":"Mauras","year":"1986","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib66","first-page":"5","article-title":"Effect of low doses of stable strontium on bone metabolism in rats","volume":"11","author":"Marie","year":"1985","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib67","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0026-0495(86)90013-2","article-title":"Short-term effects of fluoride and strontium on bone formation and resorption in the mouse","volume":"35","author":"Marie","year":"1986","journal-title":"Metabolism"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib68","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jbmr.5650080512","article-title":"An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats","volume":"8","author":"Marie","year":"1993","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib69","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1523-1755.1998.00035.x","article-title":"Strontium causes osteomalacia in chronic renal failure rats","volume":"54","author":"Schrooten","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib70","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1046\/j.1523-1755.2000.00938.x","article-title":"Increased bone strontium levels in hemodialysis patients with osteomalacia","volume":"57","author":"D\u05f3Haese","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib71","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1289\/ehp.02110699","article-title":"Cadmium and lead in blood in relation to low bone mineral density and tubular proteinuria","volume":"110","author":"Alfven","year":"2002","journal-title":"Environ Health Perspect"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2014.09.004_bib72","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/ndt\/17.suppl_2.35","article-title":"Cadmium overload and toxicity","volume":"17","author":"Jarup","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib73","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0140-6736(98)09356-8","article-title":"Environmental exposure to cadmium, forearm bone density, and risk of fractures: prospective population study. Public Health and Environmental Exposure to Cadmium (PheeCad) Study Group","volume":"353","author":"Staessen","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib74","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1359\/JBMR.040202","article-title":"Cadmium exposure and distal forearm fractures","volume":"19","author":"Alfven","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib75","first-page":"284","article-title":"Improvements in renal osteodystrophy in patients treated with lanthanum carbonate for two years","volume":"70","author":"Malluche","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib76","first-page":"192","article-title":"Encephalopathy caused by lanthanum carbonate","volume":"4","author":"Fraile","year":"2011","journal-title":"NDT Plus"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib77","first-page":"286","article-title":"Lanthanum carbonate treatment, for up to 6 years, is not associated with adverse effects on the liver in patients with chronic kidney disease stage 5 receiving hemodialysis","volume":"71","author":"Hutchison","year":"2009","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib78","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1097\/01.ASN.0000133022.32912.95","article-title":"Does the phosphate binder lanthanum carbonate affect bone in rats with chronic renal failure?","volume":"15","author":"Behets","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib79","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/01.mnh.0000133973.86816.e9","article-title":"Lanthanum carbonate: a new phosphate binder","volume":"13","author":"Behets","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib80","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0272-6386(03)00197-5","article-title":"Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients","volume":"41","author":"Bervoets","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib81","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/ndt\/gfp531","article-title":"Comment on \u05f3Lanthanum deposition in a dialysis patient\u05f3","volume":"25","author":"D\u05f3Haese","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib82","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1681\/ASN.V71135","article-title":"Influence of iron status in the response to the deferoxamine test","volume":"7","author":"Cannata","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib83","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0003-2697(88)90274-6","article-title":"Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography","volume":"169","author":"Black","year":"1988","journal-title":"Anal Biochem"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib84","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/jbmr.5650070607","article-title":"Axial and appendicular bone density predict fractures in older women","volume":"7","author":"Black","year":"1992","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib85","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1093\/ndt\/gfg403","article-title":"Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients","volume":"18","author":"Urena","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib86","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/ndt\/14.8.1917","article-title":"Usefulness of quantitative heel ultrasound compared with dual-energy X-ray absorptiometry in determining bone mineral density in chronic haemodialysis patients","volume":"14","author":"Taal","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib87","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1093\/ndt\/14.8.1922","article-title":"Risk factors for reduced bone density in haemodialysis patients","volume":"14","author":"Taal","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib88","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0272-6386(87)80149-X","article-title":"Oxalosis in bone causing a radiographical mimicry of renal osteodystrophy","volume":"9","author":"Julian","year":"1987","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib89","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib90","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00041552-200207000-00004","article-title":"Phosphorus restriction and control of coronary calcification as assessed by electron beam tomography","volume":"11","author":"Raggi","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib91","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/ndt\/gfs356","article-title":"Protocol adherence and the progression of cardiovascular calcification in the ADVANCE study","volume":"28","author":"Urena-Torres","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib92","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib93","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","article-title":"Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency","volume":"44","author":"Shigematsu","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.004_bib94","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00016.2003","article-title":"FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization","volume":"285","author":"Quarles","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929514001442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929514001442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T15:01:08Z","timestamp":1650812468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929514001442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":94,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0270929514001442"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2014.09.004","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}